About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Colorectal Cancer Clinical Trials in Arizona | 312 Studies

Clinical Trials Colorectal CancerArizona

Colorectal Cancer Clinical Trials in Arizona

Find 312 clinical trials for colorectal cancer near Arizona. Connect with research centers in your area.

All Colorectal Cancer trials nationwide All trials in Arizona

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 312 trials

CompletedGenetic Study of Patients and Families With a History of Colorectal CancerRATIONALE: Determination of genetic markers for colorectal cancer may help doctors to identify patients who are at risk.NCT00003648·Scottsdale, Arizona and 11 others TerminatedOral AMXT 1501 Dicaprate in Combination With IV DFMOA Phase 1B/2A study will be conducted to establish safety and dose level of AMXT 1501 dicaprate in combination with IV DFMO, in cancer patients.NCT05500508·Phoenix, Arizona and 6 others UnknownLiposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary CancerThis phase I/II trial studies the side effects and best dose of liposomal irinotecan and rucaparib when given together with fluorouracil and leucovorin calcium and to see how well…NCT03337087·Scottsdale, Arizona and 2 others

Colorectal Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingStudy of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS MutationThe purpose of this study is to assess 2 different doses of onvansertib to select the lowest dose that is maximally effective, and to assess the safety, efficacy…NCT06106308·Phoenix, Arizona and 40 others

TerminatedStudy of Ruxolitinib in Colorectal Cancer PatientsThe purpose of this study was to determine if ruxolitinib, in combination with regorafenib, is safe and effective in the treatment of metastatic colorectal cancer.NCT02119676·Chandler, Arizona and 85 others

TerminatedPF-06952229 Treatment in Adult Patients With Advanced Solid TumorsA Phase 1 dose escalation and expansion study evaluating safety, tolerability and pharmacokinetics of PF-06952229 in adult patients with advanced solid tumors.NCT03685591·Scottsdale, Arizona and 14 others

CompletedAn Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)This pilot, non-interventional, observational, Web-based, prospective cohort study is designed to collect self-reported safety and effectiveness and genetic data from subjects…NCT01598597·Many Locations, Alabama and 49 others

UnknownA First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid TumorsThis proposed Phase I clinical trial of SON-DP is an FIH, open-label, Phase Ia/Ib dose escalation and expansion study to evaluate the safety, tolerability, PK, and PD of SON-DP in…NCT05989724·Gilbert, Arizona and 4 others

TerminatedInformed Choice - CompassThe primary objective of this study is to evaluate the impact of a theoretically grounded video that includes information about CRC screening modality choices on CRC screening…NCT05246839·Phoenix, Arizona and 38 others

CompletedRecombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal CarcinomaThe purpose of this study is to evaluate the safety, tolerability, and efficacy of JX-594 (Pexa-Vec) administered intravenously either alone or in combination with Irinotecan in…NCT01394939·Scottsdale, Arizona and 10 others

RecruitingStudy of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid TumorsThe purpose of this platform study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of novel RAS(ON) inhibitors combined with…NCT06445062·Chandler, Arizona and 31 others

Active not recruitingS0820, Adenoma and Second Primary Prevention TrialThe investigators hypothesize that the combination of eflornithine and sulindac will be effective in reducing a three-year event rate of adenomas and second primary colorectal…NCT01349881·Birmingham, Alabama and 989 others

CompletedStudy of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard ChemotherapiesThe purpose of this study is to compare the efficacy and safety of TAS-102 versus placebo in patients with refractory metastatic colorectal cancer.NCT01607957·Glendale, Arizona and 114 others

RecruitingA Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid TumorsThis study is to evaluate the safety and tolerability to determine (i) the recommended Phase 2 dose (RP2D) of VMD-102 (Phase 1), and (ii) preliminary anti-tumor efficacy (Phase…NCT07636785·Scottsdale, Arizona

Active not recruitingRegorafenib, With Cetuximab or Panitumumab, for the Treatment of Unresectable, Locally Advanced, or Metastatic Colorectal CancerThis phase II trial how well regorafenib and anti-EGFR therapy (cetuximab or panitumumab) works for the treatment of patients with colorectal cancer that cannot be removed by…NCT04117945·Scottsdale, Arizona and 14 others

CompletedAzacitidine and Entinostat in Treating Patients With Metastatic Colorectal CancerThis phase II trial is studying how well giving azacitidine together with entinostat works in treating patients with metastatic colorectal cancer.NCT01105377·Scottsdale, Arizona and 13 others

CompletedSorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal CancerThis phase II trial is studying how well giving sorafenib together with bevacizumab works in treating patients with metastatic colorectal cancer.NCT00826540·Scottsdale, Arizona and 210 others

TerminatedA Study of ASP1951 in Subjects With Advanced Solid TumorsThe primary purpose of this study is to evaluate the tolerability and safety profile of ASP1951 when administered as a single agent and in combination with pembrolizumab in…NCT03799003·Tucson, Arizona and 31 others

TerminatedA Study of PY314 in Subjects With Advanced Solid TumorsThis is an open-label, multicenter, first in human, Phase 1a/1b study of PY314 in subjects with locally advanced (unresectable) and/or metastatic solid tumors that are refractory…NCT04691375·Phoenix, Arizona and 22 others

TerminatedPembrolizumab and Monoclonal Antibody Therapy in Advanced CancerThere will be two phase II cohorts for pembro plus trastuzumab: one cohort will be for patients with unresectable HER2 overexpressing gastric or GEJ cancers, the other cohort will…NCT02318901·Goodyear, Arizona

Page 1 of 16Next

Other Conditions in Arizona

Breast Cancer Lung Cancer Prostate Cancer Melanoma Leukemia Lymphoma